Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Envu, formerly known as Bayer Environmental Science, is a global leader in the environmental science sector, focusing on professional pest management, vector control, and turf and ornamental solutions. The company provides innovative chemical and biological solutions to manage pests and diseases that impact public health and infrastructure. Envu plays a critical role in global health by developing products to combat vector-borne diseases such as malaria and dengue. Following its acquisition by Cinven from Bayer in 2022, the company operates as a standalone entity dedicated to environmental health and sustainability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Environment Science.